Pharming Group (NASDAQ:PHAR – Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.02), Zacks reports. Pharming Group had a negative return on equity of 7.65% and a negative net margin of 6.09%. The company had revenue of $92.70 million during the quarter, compared to the consensus estimate of $76.67 million. Pharming Group updated its FY 2025 guidance to EPS.
Pharming Group Stock Up 0.3 %
PHAR opened at $8.77 on Friday. The company has a 50 day moving average of $8.99 and a 200 day moving average of $8.58. The company has a current ratio of 3.53, a quick ratio of 2.76 and a debt-to-equity ratio of 0.41. Pharming Group has a 12 month low of $6.65 and a 12 month high of $11.80. The company has a market cap of $596.63 million, a PE ratio of -33.73 and a beta of -0.10.
Analyst Ratings Changes
A number of research firms recently commented on PHAR. Oppenheimer lifted their price target on shares of Pharming Group from $30.00 to $39.00 and gave the stock an “outperform” rating in a report on Friday. Jefferies Financial Group began coverage on Pharming Group in a research note on Monday, December 9th. They issued a “buy” rating and a $14.00 target price on the stock. Finally, HC Wainwright reiterated a “buy” rating and set a $37.00 price target on shares of Pharming Group in a research note on Friday.
Pharming Group Company Profile
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Read More
- Five stocks we like better than Pharming Group
- Golden Cross Stocks: Pattern, Examples and Charts
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Investing in Travel Stocks Benefits
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- Most Volatile Stocks, What Investors Need to Know
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
